Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 407

1.

BCLC stage B hepatocellular carcinoma and transcatheter arterial chemoembolization: a 20-year survey by the Italian Liver Cancer group.

Farinati F, Vanin V, Giacomin A, Pozzan C, Cillo U, Vitale A, Di Nolfo AM, Del Poggio P, Benvegnu' L, Rapaccini G, Zoli M, Borzio F, Giannini EG, Caturelli E, Trevisani F; Italian Liver Cancer (ITA.LI.CA) group.

Liver Int. 2015 Jan;35(1):223-31. doi: 10.1111/liv.12649. Epub 2014 Aug 27.

PMID:
25074434
2.

Rationality and effectiveness of transarterial chemoembolization as an initial treatment for BCLC B stage HBV-related hepatocellular carcinoma.

Heng-jun G, Yao-jun Z, Min-shan C, Mei-xian C, Jun-ting H, Li X, Lau WY.

Liver Int. 2014 Apr;34(4):612-20. doi: 10.1111/liv.12307. Epub 2013 Sep 13.

PMID:
24028297
3.

Optimizing the management of patients with BCLC stage-B hepatocellular carcinoma: Modern surgical resection as a feasible alternative to transarterial chemoemolization.

Ciria R, López-Cillero P, Gallardo AB, Cabrera J, Pleguezuelo M, Ayllón MD, Luque A, Zurera L, Espejo JJ, Rodríguez-Perálvarez M, Montero JL, de la Mata M, Briceño J.

Eur J Surg Oncol. 2015 Sep;41(9):1153-61. doi: 10.1016/j.ejso.2015.05.023. Epub 2015 Jun 12.

PMID:
26118317
4.

Development of Hong Kong Liver Cancer staging system with treatment stratification for patients with hepatocellular carcinoma.

Yau T, Tang VY, Yao TJ, Fan ST, Lo CM, Poon RT.

Gastroenterology. 2014 Jun;146(7):1691-700.e3. doi: 10.1053/j.gastro.2014.02.032. Epub 2014 Feb 25.

PMID:
24583061
5.

Overall survival in response to sorafenib with transarterial chemoembolization for BCLC stage B hepatocellular carcinoma: propensity score analysis
.

Huang Y, Chen B, Liu N, Li N, Dao H, Chen W, Yang J.

Int J Clin Pharmacol Ther. 2017 Jun;55(6):498-508. doi: 10.5414/CP202787.

PMID:
28157070
6.

Prognostic factors for survival in patients with unresectable hepatocellular carcinoma undergoing chemoembolization with doxorubicin drug-eluting beads: a preliminary study.

Dhanasekaran R, Kooby DA, Staley CA, Kauh JS, Khanna V, Kim HS.

HPB (Oxford). 2010 Apr;12(3):174-80. doi: 10.1111/j.1477-2574.2009.00138.x.

7.

Treatment of hepatocellular carcinoma in a tertiary Romanian center. Deviations from BCLC recommendations and influence on survival rate.

Radu P, Groza I, Iancu C, Al Hajjar N, Andreica V, Sparchez Z.

J Gastrointestin Liver Dis. 2013 Sep;22(3):291-7.

8.

Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching.

Chen RX, Gan YH, Ge NL, Chen Y, Ma H, Wang Y, Zhang BH, Wang YH, Ye SL, Luo JF, Ren ZG.

J Gastroenterol Hepatol. 2016 Feb;31(2):442-9. doi: 10.1111/jgh.13077.

PMID:
26259976
9.

Comparison of survival of patients with BCLC stage A hepatocellular carcinoma after hepatic resection or transarterial chemoembolization: a propensity score-based analysis.

Guo Z, Zhong JH, Jiang JH, Zhang J, Xiang BD, Li LQ.

Ann Surg Oncol. 2014 Sep;21(9):3069-76. doi: 10.1245/s10434-014-3704-8. Epub 2014 Apr 12.

PMID:
24728740
10.

Comparison of the effects of transarterial chemoembolization for advanced hepatocellular carcinoma between patients with and without extrahepatic metastases.

Yoo JJ, Lee JH, Lee SH, Lee M, Lee DH, Cho Y, Lee YB, Yu SJ, Kim HC, Kim YJ, Yoon JH, Kim CY, Lee HS.

PLoS One. 2014 Nov 26;9(11):e113926. doi: 10.1371/journal.pone.0113926. eCollection 2014.

11.

Comparison of long-term survival of patients with BCLC stage B hepatocellular carcinoma after liver resection or transarterial chemoembolization.

Zhong JH, Xiang BD, Gong WF, Ke Y, Mo QG, Ma L, Liu X, Li LQ.

PLoS One. 2013 Jul 9;8(7):e68193. doi: 10.1371/journal.pone.0068193. Print 2013.

12.

Clinical prognostic value of CD4+CD25+FOXP3+regulatory T cells in peripheral blood of Barcelona Clinic Liver Cancer (BCLC) stage B hepatocellular carcinoma patients.

Li F, Guo Z, Lizée G, Yu H, Wang H, Si T.

Clin Chem Lab Med. 2014 Sep;52(9):1357-65. doi: 10.1515/cclm-2013-0878.

PMID:
24646790
13.
14.

Comparison of long-term survival of patients with solitary large hepatocellular carcinoma of BCLC stage A after liver resection or transarterial chemoembolization: a propensity score analysis.

Zhu SL, Ke Y, Peng YC, Ma L, Li H, Li LQ, Zhong JH.

PLoS One. 2014 Dec 26;9(12):e115834. doi: 10.1371/journal.pone.0115834. eCollection 2014.

15.

HKLC Triages More Hepatocellular Carcinoma Patients to Curative Therapies Compared to BCLC and Is Associated with Better Survival.

Wallace MC, Huang Y, Preen DB, Garas G, Adams LA, MacQuillan G, Tibballs J, Ferguson J, Samuelson S, Jeffrey GP.

Dig Dis Sci. 2017 Aug;62(8):2182-2192. doi: 10.1007/s10620-017-4622-y. Epub 2017 May 25.

PMID:
28547649
17.

Barcelona clinic liver cancer stage B hepatocellular carcinoma: transarterial chemoembolization or hepatic resection?

Jianyong L, Lunan Y, Wentao W, Yong Z, Bo L, Tianfu W, Minqing X, Jiaying Y.

Medicine (Baltimore). 2014 Nov;93(26):e180. doi: 10.1097/MD.0000000000000180.

18.

The ART score is not effective to select patients for transarterial chemoembolization retreatment in an Italian series.

Terzi E, Terenzi L, Venerandi L, Croci L, Renzulli M, Mosconi C, Allegretti G, Granito A, Golfieri R, Bolondi L, Piscaglia F.

Dig Dis. 2014;32(6):711-6. doi: 10.1159/000368007. Epub 2014 Oct 29.

PMID:
25376288
19.

Role of hepatic resection in patients with intermediate-stage hepatocellular carcinoma: A multicenter study from Japan.

Tada T, Kumada T, Toyoda H, Tsuji K, Hiraoka A, Itobayashi E, Nouso K, Kariyama K, Ishikawa T, Hirooka M, Hiasa Y.

Cancer Sci. 2017 Jul;108(7):1414-1420. doi: 10.1111/cas.13257. Epub 2017 May 23.

20.

Transcatheter Arterial Chemoembolization With Gelatin Sponge Microparticles Treated for BCLC Stage B Hepatocellular Carcinoma: A Single Center Retrospective Study.

Kamran AU, Liu Y, Li FE, Liu S, Wu JL, Zhang YW.

Medicine (Baltimore). 2015 Dec;94(52):e2154. doi: 10.1097/MD.0000000000002154.

Supplemental Content

Support Center